Chapter

Topical Drug Bioavailability, Bioequivalence, and Penetration

pp 431-436

Clinical Considerations of Transdermal Drugs

  • Solomon SobelAffiliated withDivision of Metabolism and Endocrine Drug Products, Food and Drug Administration

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Mountain climbers have been known to say that they are challenged by a peak basically “because it is there.” Analogously, researchers and manufacturers may try to apply technologies just because they are available.